IP Library › Assignment 068933/0437
Patent Assignment
Reel/Frame 068933/0437

Assignment of Assignor's Interest

Recorded: 2024-10-17 Pages: 8
Assignor
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA, 540-8645, JAPAN
Covered Properties (3)
Formulation for Anti-ALPHA4BETA7 Antibody
Application: 15/983,791 →
Publication: US 2018/0327497
Formulation for Anti-ALPHA4BETA7 Antibody
Application: 16/009,865 →
Publication: US 2018/0346578
Formulation for Anti-ALPHA4BETA7 Antibody
Application: 18/912,587 →
Publication: US 2025/0034263
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 17, 2024
From: JENKINS, HELEN
To: TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER (EUROPE), LTD.
Reel/Frame 068933/0431 →
Assignment of Assignor's Interest Oct 17, 2024
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 068933/0474 →
Assignment of Assignor's Interest Oct 17, 2024
From: DILUZIO, WILLOW; NGUYEN, PHUONG M.; VARGA, CSANAD M.; PALANIAPPAN, VAITHIANATHAN
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 068933/0401 →
Assignment of Assignor's Interest Oct 17, 2024
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 068933/0459 →